Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the PROTECHT and TOPIC-2 studies.
Verso
M
M
Gussoni
G
G
Agnelli
G
G
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000150:complications / Q000188:drug therapy*; D011292:Premedication / Q000379:methods; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000517:prevention & control*
D000970:Antineoplastic Agents; D006495:Heparin, Low-Molecular-Weight